Report - LifeSciences BC

More documents

Recommendations

Info

the function of the Therapeutics Initiativeshould be focused on therapeuticevaluation. Activities beyond that coremandate such as public education should bereassigned to the PSD's Drug UtilizationUnit where an accountable process can beimplemented to assure the unbiased andevidence-based practices;the practice of having members of theTherapeutics Initiative also participating inthe work of the Drug Benefits Committeeshould be terminated.THE REPORT OF PHARMACEUTICAL POLICY RECOMMENDATIONS FOR THE MINISTRY OF HEALTH 29 APRIL, 2008
THE REPORT OF PHARMACEUTICAL POLICY RECOMMENDATIONS FOR THE MINISTRY OF HEALTH 30 APRIL, 2008
Page 1 and 2: REPORT OF THE PHARMACEUTICAL TASK F
Page 3 and 4: Table of ContentsTask Force Mandate
Page 5 and 6: In addition to the submissions from
Page 7 and 8: pharmaceutical coverage programs ha
Page 9 and 10: these factors may potentially resul
Page 11 and 12: 14formulary”; andBC should benchm
Page 13 and 14: meaningful engagement with stakehol
Page 15 and 16: contributions from Drs. Ken Bassett
Page 17 and 18: Recommendations for an Improved Lis
Page 19 and 20: Generic Drugs - Call for aFundament
Page 21 and 22: The Task Force also considered thea
Page 23 and 24: was understood that the cost of the
Page 25 and 26: The Task Force believes this is an
Page 27 and 28: participation in decision making, t
Page 29 and 30: Recommendation Twelve:Subject to Re
Page 31: Recommendation Eight: To increase t

Report - LifeSciences BC

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?